首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Tricyclic aminopyrimidine histamine H4 receptor antagonists
Authors:Savall Brad M  Gomez Laurent  Chavez Frank  Curtis Michael  Meduna Steven P  Kearney Aaron  Dunford Paul  Cowden Jeffery  Thurmond Robin L  Grice Cheryl  Edwards James P
Institution:Johnson & Johnson Pharmaceutical Research & Development, LLC 3210 Merryfield Row, San Diego, CA 92121, USA. bsavall@its.jnj.com
Abstract:This report discloses the development of a series of tricyclic histamine H(4) receptor antagonists. Starting with a low nanomolar benzofuranopyrimidine HTS hit devoid of pharmaceutically acceptable properties, we navigated issues with metabolism and solubility to furnish a potent, stable and water soluble tricyclic histamine H(4) receptor antagonist with desirable physiochemical parameters which demonstrated efficacy a mouse ova model.
Keywords:Histamine  Histamine H4  Antagonists  Benzofuran  Amino pyrimidine  Tricyclic
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号